13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 48 holding rows worth $495,150,000.
- Accession
- 0001493152-20-015902
- Filer
- CIK 1595855
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 48 entries on the cover page, a total value of $495,150,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $495,150,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 2,208,472 | $64,752,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 5,984,200 | $49,848,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 1,400,000 | $23,240,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 361,600 | $20,816,000 | thousands by filing date | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 3,640,000 | $19,838,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 3,130,000 | $19,750,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 1,400,000 | $16,089,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 3,511,500 | $15,661,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 315,550 | $14,634,000 | thousands by filing date | |
| HARROW INC | 415858109 | COM | 2,710,000 | $14,119,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 682,500 | $14,073,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 501,000 | $13,988,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,071,000 | $13,923,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 222,000 | $13,081,000 | thousands by filing date | |
| AVENUE THERAPEUTICS INC | 05360L205 | COM | 1,035,000 | $11,147,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 250,000 | $10,585,000 | thousands by filing date | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 3,830,000 | $10,264,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 456,600 | $8,895,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 344,500 | $8,778,000 | thousands by filing date | |
| CERECOR INC | 15671L109 | COM | 3,372,500 | $8,768,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 270,400 | $8,547,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 114,350 | $8,360,000 | thousands by filing date | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 415,380 | $8,208,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 435,200 | $7,625,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 303,050 | $7,143,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 495,000 | $6,826,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 238,300 | $6,548,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 2,105,000 | $6,526,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 1,556,000 | $6,426,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 146,000 | $5,688,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 461,500 | $5,584,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 1,155,000 | $5,336,000 | thousands by filing date | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 94,000 | $4,983,000 | thousands by filing date | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 1,878,500 | $4,648,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 361,000 | $3,794,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 970,664 | $3,582,000 | thousands by filing date | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 400,000 | $3,368,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 471,600 | $3,263,000 | thousands by filing date | |
| TELA BIO INC | 872381108 | COM | 250,000 | $3,240,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 455,000 | $3,149,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 590,000 | $2,956,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 960,000 | $2,458,000 | thousands by filing date | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 171,000 | $1,428,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 175,000 | $1,085,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 60,000 | $962,000 | thousands by filing date | |
| Indivior Pharmaceuticals Inc | 04546C106 | COMMON STOCK | 880,000 | $754,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 51,225 | $385,000 | thousands by filing date | |
| NULL | 09071M205 | NULL | 16,667 | $29,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-20-015902 | this filing | 2020-08-14 | acceptance time not in the bulk data set |